Security key
H17182108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 56,683,321
- Total 13F value
- $3,701,432,142
- Share change
- -1,243,138
- Put/Call ratio
- 94%
- SEC-reported price per share
- $65.35
- Number of holders
- 410
- Value change
- -$78,744,860
- Number of buys
- 171
- Number of sells
- 161
- Shares outstanding
- 96,232,072
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
410
Top holders
10
CRSP full security history
Ownership snapshot
Full 13F holder table
CRISPR Therapeutics AG SEC filings
CRISPR Therapeutics AG company facts
Broader feeds
Ownership snapshot
Top reported holders of CRSP - CRISPR Therapeutics AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
10%
Capital International Investors
4.8%
Sumitomo Mitsui Trust Group, Inc.
4.8%
Amova Asset Management Americas, ...
4.8%
PRICE T ROWE ASSOCIATES INC /MD/
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
10%
|
$564,683,000
9,727,531 shares
|
— | 30 Jun 2022 |
| Capital International Investors |
13F
Company
|
4.8%
|
$283,428,000
4,663,954 shares
|
— | 30 Jun 2022 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
4.8%
|
$278,576,000
4,584,098 shares
|
— | 30 Jun 2022 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
4.8%
|
$276,054,000
4,584,098 shares
|
— | 30 Jun 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.1%
|
$183,194,000
3,014,551 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
2.2%
|
$130,785,000
2,152,126 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
410
Shares
56,683,321
Rows available
410
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
404
Q3 2022 holders
410
Holder diff
6
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|